China National Pharmaceutical Group: The registration certificate for the injection solution of hydrochloric acid n-butyl acrylate has been obtained.

Guoyao Modern announced on the evening of September 16th that its wholly-owned subsidiary, Guoyao Industrial, has received the drug registration certificate for the injection of butylscopolamine hydrobromide issued by the National Medical Products Administration. Butylscopolamine hydrobromide injection is a selective anticholinergic drug, mainly used for pre-anesthetic medication to inhibit salivary and bronchial gland secretions, as well as for emergency treatment of organophosphate poisoning and maintenance of atropine after poisoning or cholinesterase aging.